...
首页> 外文期刊>American Family Physician >Amoxicillin/clavulanate or ibuprofen no better than placebo for acute bronchitis
【24h】

Amoxicillin/clavulanate or ibuprofen no better than placebo for acute bronchitis

机译:阿莫西林/克拉维丁酸或布洛芬没有比安慰剂更好的急性支气管炎

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In adults with discolored sputum and acute bronchitis, is treatment with amoxicillin/ clavulanate (Augmentin) or ibuprofen more effective than placebo in decreasing the number of days with frequent cough? Treating acute bronchitis with amoxicillin/ clavulanate or the nonsteroidal anti-inflammatory drug ibuprofen is no more effective than placebo in decreasing symptoms in general or duration of frequent cough. Treatment does, however, produce adverse effects in one in eight patients. To quote Osier: "The desire to take medicine is perhaps the greatest feature which distinguishes man from animals." In that case, prescribing ibuprofen rather than an antibiotic may be the better way to allow patients to take medicine while their cough resolves. (Level of Evidence = 1b)
机译:在具有变色的痰和急性支气管炎的成年人中,用阿莫西林/克拉维酸盐(Augmentin)或布洛芬的治疗比安慰剂更有效地减少频繁咳嗽的天数? 用阿莫西林/克拉维酸盐或非甾体抗炎药物对急性支气管炎或非甾体抗炎药布洛芬没有比安慰剂更有效,以减少繁殖或频繁咳嗽的持续时间。 然而,治疗在八个患者中产生不利影响。 引用Osier:“服用药物的愿望可能是与动物的人区分开的最大特征。” 在这种情况下,要求布洛芬而不是抗生素可能是让患者在咳嗽解决时服用药物的更好方法。 (证据水平= 1B)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号